Extraperitoneal versus Transperitoneal Single-Port Robotic Radical Prostatectomy: A Comparative Analysis of Perioperative Outcomes. - UroToday

-

To compare intraoperative and perioperative outcomes between extraperitoneal and transperitoneal radical prostatectomy performed by using a "purpose-designed" single-port robotic platform.

98 patients underwent single-port robotic prostatectomy using the da Vinci SP® robotic system with extraperitoneal (Group I (n=52)) versus transperitoneal (Group II (n=46)) approach. Demographics and perioperative data including postoperative recovery outcomes were recorded and compared between the two groups.

Groups were similar regarding demographics and prostate cancer risk category. Mean operative time (201± 37.5 min vs. 248.2 ± 42.3 min; p< 0.00001) as well as median postoperative hospital stay (4.3 vs. 25.7 hours p<0.0001) was significatly shorter with extraperitoneal approach. Overall need for pain medications or narcotics as well as the required amount of narcotics per patient (if administered) were significantly lower with the extraperitoneal approach. Extraprostatic extension was detected in 48.1% vs. 41.3% of patients in Groups I and II; respectively. Surgical margins were positive in 26.9% in Group I vs. 41.3% of patients Group II (p=0.13). More than 80% of patients with positive surgical margins had high risk features on final surgical pathology. 90-day continence rate was similar between the two groups (60% vs. 62.5%; p=0.82).

Extraperitoneal and transperitoneal single-port robotic radical prostatectomy are safe and feasible approaches. The extraperitoneal approach is associated with a significantly shorter postoperative hospital stay and decreased need for postoperative narcotics. Randomized trials with adequate sample size and postoperative follow up are advisable for further evaluation of the outcomes to clarify patient selection criteria for each approach.

The Journal of urology. 2019 Dec 17 [Epub ahead of print]

Jihad Kaouk, Alireza Aminsharifi, Clark A Wilson, Guilherme Sawczyn, Juan Garisto, Simone Francavilla, Michael Abern, Simone Crivellaro

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio., Department of Urology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.

PubMed https://ift.tt/2QvCFGK



Comments

Post a Comment

Popular posts from this blog

I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...

-
Image
efudex side effects :: Article Creator Inmates Given Ivermectin In Jail Will Each Get $2,000 After Settlement Your browser is not supporteddetroitnews.Com detroitnews.Com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on detroitnews.Com Efudex Cream Efudex Cream Generic Name & Formulations General Description Fluorouracil 5%. Pharmacological Class Antimetabolite. How Supplied Soln (w. Drop dispenser)—10mL, 25mL; Crm—40g Efudex Cream Indications Indications Multiple actinic or solar keratoses. Superficial basal cell carcinoma when conventional therapy is impractical (5% only); see full labeling. Efudex Cream Dosage and Administration Adult Keratoses: Apply twice daily until eros
Read more

Early symptoms of cancer in males: Common warning signs

-
Image
fluciclovine f 18 :: Article Creator The U.S. Navy Might Be Done With The F/A-18 Super Hornet Fighter Will The U.S. Navy Receive Its Final F/A-18 Super Hornets? - Around the holidays, money can be tight, a fact that the United States Navy has also learned as its negotiations to buy the last batch of Super Hornets are reportedly stalled over the growing price tag. USNI News reported on Tuesday that the contract for the U.S. Navy to purchase the final twenty F/A-18 E/F Super Hornets from aerospace giant Boeing appears to be at a standstill. The Navy continues to work with Boeing on the contract for the 20 congressionally added Super Hornet aircraft. Ongoing contract negotiations cannot be discussed at this time," Capt. Michael Burks, the program manager for the F/A-18 and EA-18G office at Naval Air Systems Command, told USNI News in a statement. Previous estimates put the unit cost of the final batch of aircraft at $55.7 million, and la
Read more

20 Famous Men Who Have Had Prostate Cancer

-
Image
leukemia treatment options :: Article Creator Current And Breakthrough Treatments For Chronic Lymphocytic Leukemia (CLL) Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the immune system. Because it's slow-growing, many people with CLL won't need to start treatment for many years after their diagnosis. Once the cancer begins to grow, there are many available treatment options that can help people achieve remission. This means people can experience long periods of time when there's no sign of cancer in their bodies. The exact treatment option that you'll receive depends on a variety of factors. This includes: whether your CLL is symptomatic the stage of the CLL, based on results of blood tests and a physical exam your age your overall health While there's no cure for CLL yet, breakthroughs in the field are on the horizon. Doctors typically stage CLL using a system called the Rai system. Low
Read more